Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Relapse Prevention After 10-Week and 52-Week Treatment with Tomoxetine Hydrochloride in Children with Attention-Deficit/Hyperactivity Disorder
Atomoxetine
B4Z-MC-LYAF
Not available
Attention Deficit Hyperactivity Disorder
Phase 2/Phase 3
 
A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
November 2014

Powered by ideaPoint, Inc.